Literature DB >> 11991282

Eotaxin and CCR3 are up-regulated in exacerbations of chronic bronchitis.

V Bocchino1, G Bertorelli, C P Bertrand, P D Ponath, W Newman, C Franco, A Marruchella, S Merlini, M Del Donno, X Zhuo, D Olivieri.   

Abstract

BACKGROUND: Eosinophils and T lymphocytes represent constant features in the airways of subjects with exacerbated chronic bronchitis. Eotaxin is the most potent and selective eosinophil chemoattractant which can also attracts lymphocytes. The aim of the study was to evaluate the expression of eotaxin and its receptor, CCR3, in bronchial airways during exacerbation of chronic bronchitis.
METHODS: By immunohistochemistry we studied eotaxin and CCR3 expression in the lamina propria of 14 subjects with acute exacerbation of chronic bronchitis. 20 asthmatics, and 8 healthy subjects. We determined the cell types expressing the CCR3 receptor by colocalization experiments. We finally studied the relationship between eotaxin and CCR3 and eosinophils and T lymphocytes.
RESULTS: The number of eotaxin+ and CCR3+ cells was significantly higher in exacerbated chronic bronchitis (P<0.003 and P<0.002) and asthma (P<0.002 and P<0.0001) when compared to healthy subjects. CCR3 was mainly expressed by eosinophils and to a lesser extent by CD4+ and CD8+ lymphocytes. In exacerbated chronic bronchitis the number of CCR3+ cells was strongly correlated to the number of eosinophils (P<0.0002. r=0.85) and to the number of CD4+ lymphocytes (P<0.05, r=0.57).
CONCLUSION: Our study suggests that eotaxin and CCR3 are up-regulated and could be involved in the eosinophil and CD4+ lymphocyte recruitment into the airways which occur during acute exacerbations of chronic bronchitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991282

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

1.  Protective effect of eotaxin-2 inhibition in adjuvant-induced arthritis.

Authors:  J N Ablin; M Entin-Meer; V Aloush; S Oren; O Elkayam; J George; I Barshack
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

3.  The value of blood cytokines and chemokines in assessing COPD.

Authors:  Eric Bradford; Sean Jacobson; Jason Varasteh; Alejandro P Comellas; Prescott Woodruff; Wanda O'Neal; Dawn L DeMeo; Xingnan Li; Victor Kim; Michael Cho; Peter J Castaldi; Craig Hersh; Edwin K Silverman; James D Crapo; Katerina Kechris; Russell P Bowler
Journal:  Respir Res       Date:  2017-10-24

4.  CD8 chemokine receptors in chronic obstructive pulmonary disease.

Authors:  L J C Smyth; C Starkey; F S Gordon; J Vestbo; D Singh
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

Review 5.  Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.

Authors:  Maria Tsoumakidou; Nikolaos M Siafakas
Journal:  Respir Res       Date:  2006-05-22

6.  Multiple exposures to swine barn air induce lung inflammation and airway hyper-responsiveness.

Authors:  Chandrashekhar Charavaryamath; Kyathanahalli S Janardhan; Hugh G Townsend; Philip Willson; Baljit Singh
Journal:  Respir Res       Date:  2005-06-02

7.  Eosinophil and T cell markers predict functional decline in COPD patients.

Authors:  Jeanine M D'Armiento; Steven M Scharf; Michael D Roth; John E Connett; Andrew Ghio; David Sternberg; Jonathan G Goldin; Thomas A Louis; Jenny T Mao; George T O'Connor; Joe W Ramsdell; Andrew L Ries; Neil W Schluger; Frank C Sciurba; Melissa A Skeans; Helen Voelker; Robert E Walter; Christine H Wendt; Gail G Weinmann; Robert A Wise; Robert F Foronjy
Journal:  Respir Res       Date:  2009-11-19

Review 8.  Airways inflammation and treatment during acute exacerbations of COPD.

Authors:  Erik Bathoorn; Huib Kerstjens; Dirkje Postma; Wim Timens; William MacNee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

9.  Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.

Authors:  Janet S Lee; Matthew R Rosengart; Venkateswarlu Kondragunta; Yingze Zhang; Jessica McMurray; Robert A Branch; Augustine M K Choi; Frank C Sciurba
Journal:  Respir Res       Date:  2007-09-14

Review 10.  Pulmonary biomarkers in COPD exacerbations: a systematic review.

Authors:  Angela Koutsokera; Konstantinos Kostikas; Laurent P Nicod; Jean-William Fitting
Journal:  Respir Res       Date:  2013-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.